{"slideshow_credits": null, "snippet": "With each tactical maneuver \u2014 the proposed board members being the latest \u2014 the Pershing Square hedge fund and the drug maker Valeant continue to ratchet up the pressure on Allergan.", "abstract": "With each tactical maneuver \u2014 the proposed board members being the latest \u2014 the Pershing Square hedge fund and the drug maker Valeant continue to ratchet up the pressure on Allergan.", "section_name": "Business Day", "print_page": null, "document_type": "blogpost", "byline": {"person": [{"firstname": "David", "role": "reported", "lastname": "GELLES", "rank": 1, "organization": ""}], "original": "By DAVID GELLES"}, "web_url": "http://dealbook.nytimes.com/2014/07/07/pershing-square-offers-slate-of-directors-for-allergan/", "lead_paragraph": null, "headline": {"main": "Ackman's Hedge Fund Offers Slate of Directors for Botox Maker Allergan", "print_headline": "Slate of Nominees", "kicker": "DealBook"}, "_id": "53badea138f0d847f10f5bbf", "word_count": "493", "multimedia": [{"height": 126, "url": "images/2014/07/08/business/dbpix-black/dbpix-black-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2014/07/08/business/dbpix-black/dbpix-black-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 400, "url": "images/2014/07/08/business/dbpix-black/dbpix-black-articleLarge.jpg", "legacy": {"xlarge": "images/2014/07/08/business/dbpix-black/dbpix-black-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "400"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2014/07/08/business/dbpix-black/dbpix-black-thumbStandard-v2.jpg", "legacy": {"thumbnail": "images/2014/07/08/business/dbpix-black/dbpix-black-thumbStandard-v2.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2014-07-07T13:52:57Z", "source": "The New York Times", "news_desk": "Business", "keywords": [{"name": "persons", "value": "Ackman, William A", "rank": "1"}, {"name": "persons", "value": "Black, Cathleen P", "rank": "2"}, {"name": "organizations", "value": "Pershing Square Capital Management", "rank": "2"}, {"name": "organizations", "value": "Valeant Pharmaceuticals International Inc", "rank": "3"}, {"name": "organizations", "value": "Allergan Inc", "rank": "1"}, {"name": "subject", "value": "Shareholder Rights and Activism", "rank": "3"}, {"name": "subject", "value": "Mergers, Acquisitions and Divestitures", "rank": "2"}, {"name": "subject", "value": "Boards of Directors", "rank": "1"}], "blog": [], "subsection_name": "Dealbook", "type_of_material": "Blog"}